HIGHLIGHTS
SUMMARY
Catatonia is a complex neuropsychiatric syndrome, firstly described by Kahlbaum in 1874 as a motor syndrome occurring in association with affective disorders, epilepsy and tuberculosis. Given the poor treatment efficacy and the prominence of catatonic and affective symptoms, intravenous (IV) Lorazepam (4 mg vial three times a day) and IV Sodium Valproate (400 mg three times a day), followed after three days by oral Sodium Valproate 1000 mg/day, Lithium salts (up to 20 mmol/l) and Gabapentin 900 mg/day were prescribed, with discontinuation of the antipsychotics. The antipsychotic was newly reduced to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.